These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24158818)

  • 1. HIV-1 accessory proteins: Nef.
    Heigele A; Sauter D; Münch J; Kirchhoff F
    Methods Mol Biol; 2014; 1087():115-23. PubMed ID: 24158818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses.
    Münch J; Rajan D; Schindler M; Specht A; Rücker E; Novembre FJ; Nerrienet E; Müller-Trutwin MC; Peeters M; Hahn BH; Kirchhoff F
    J Virol; 2007 Dec; 81(24):13852-64. PubMed ID: 17928336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
    Welker R; Kottler H; Kalbitzer HR; Kräusslich HG
    Virology; 1996 May; 219(1):228-36. PubMed ID: 8623533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
    Usami Y; Wu Y; Göttlinger HG
    Nature; 2015 Oct; 526(7572):218-23. PubMed ID: 26416733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.
    Fackler OT
    Viruses; 2015 Dec; 7(12):6730-8. PubMed ID: 26703715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.
    Wiskerchen M; Cheng-Mayer C
    Virology; 1996 Oct; 224(1):292-301. PubMed ID: 8862424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.
    Li M; Waheed AA; Yu J; Zeng C; Chen HY; Zheng YM; Feizpour A; Reinhard BM; Gummuluru S; Lin S; Freed EO; Liu SL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5705-5714. PubMed ID: 30842281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
    Rosa A; Chande A; Ziglio S; De Sanctis V; Bertorelli R; Goh SL; McCauley SM; Nowosielska A; Antonarakis SE; Luban J; Santoni FA; Pizzato M
    Nature; 2015 Oct; 526(7572):212-7. PubMed ID: 26416734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus-1 Nef suppresses Hsp70-mediated Tat activation.
    Sugiyama R; Naganuma H; Nishitsuji H; Takaku H
    FEBS Lett; 2011 Nov; 585(21):3367-71. PubMed ID: 21970979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
    Trautz B; Wiedemann H; Lüchtenborg C; Pierini V; Kranich J; Glass B; Kräusslich HG; Brocker T; Pizzato M; Ruggieri A; Brügger B; Fackler OT
    J Biol Chem; 2017 Aug; 292(33):13702-13713. PubMed ID: 28659343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry.
    Tokunaga K; Ikuta K; Adachi A; Matsuda M; Kurata T; Kojima A
    Virology; 1999 May; 257(2):285-9. PubMed ID: 10329538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
    Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
    Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Polycomb group EED protein negatively affects HIV-1 assembly and release.
    Rakotobe D; Tardy JC; André P; Hong SS; Darlix JL; Boulanger P
    Retrovirology; 2007 Jun; 4():37. PubMed ID: 17547741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 downregulation by the human immunodeficiency virus type 1 Nef protein is dispensable for optimal output and functionality of viral particles in primary T cells.
    Neri F; Giolo G; Potestà M; Petrini S; Doria M
    J Gen Virol; 2011 Jan; 92(Pt 1):141-50. PubMed ID: 20881088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of HIV-1 Nef mutants in the context of viral infection.
    Fackler OT; Moris A; Tibroni N; Giese SI; Glass B; Schwartz O; Kräusslich HG
    Virology; 2006 Aug; 351(2):322-39. PubMed ID: 16684552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor.
    Vigerust DJ; Egan BS; Shepherd VL
    J Leukoc Biol; 2005 Apr; 77(4):522-34. PubMed ID: 15637102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.
    Laguette N; Benichou S; Basmaciogullari S
    J Virol; 2009 Jan; 83(2):1093-104. PubMed ID: 18987145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
    Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
    Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.